Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Evolus Inc (NQ: EOLS ) 15.95 -0.40 (-2.45%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Evolus Inc < Previous 1 2 3 4 5 6 Next > Recap: Evolus Q4 Earnings March 07, 2024 Via Benzinga Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance March 07, 2024 From Evolus Via Business Wire Evolus Announces Results from European Head-to-Head Filler Trial March 01, 2024 From Evolus Via Business Wire Evolus to Participate in Upcoming Leerink Partners and Barclays Investor Conferences February 27, 2024 From Evolus Via Business Wire AbbVie Stock Clears Key Benchmark, Hitting 80-Plus RS Rating February 14, 2024 A Relative Strength Rating upgrade for AbbVie shows improving technical performance. Via Investor's Business Daily Evolus Inc. (NASDAQ: EOLS) Leading the Way in Wednesday Trading Based on Percentage Gain January 17, 2024 Via Investor Brand Network Earnings Scheduled For March 7, 2024 March 07, 2024 Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. Via Benzinga Earnings Outlook For Evolus March 06, 2024 Via Benzinga Evolus to Report Fourth Quarter and Year End 2023 Results and Provide Business Update on March 7, 2024 February 22, 2024 From Evolus Via Business Wire Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 09, 2024 From Evolus Via Business Wire Novo Nordisk Stock Just Earned A 92 RS Rating; Gapped Up On Earnings February 01, 2024 Novo Nordisk ADR sees its Relative Strength Rating move into the elite 90-plus level. Via Investor's Business Daily Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 29, 2024 Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped... Via Benzinga SoFi Technologies Posts Q4 Earnings, Joins Cardlytics, McGrath RentCorp And Other Big Stocks Moving Higher On Monday January 29, 2024 U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday. Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) rose sharply during Monday’s session after the company reported... Via Benzinga Topics Stocks Exposures US Equities Evolus Set For Promising 2024: Analysts Maintain Positive Outlook On Botox Alternative Maker January 17, 2024 Evolus beats Q4 revenue expectations, up 40% YoY at $61M. Full-year 2023 hits $202M, exceeding guidance. Analysts bullish on Evolus. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 17, 2024 Via Benzinga Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue, Achieving Record Results and Exceeding Expectations; Issues 2024 Guidance January 16, 2024 From Evolus Via Business Wire Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) January 12, 2024 From Evolus Via Business Wire Aesthetics Market Resilience: AbbVie Asserts Widely Used Botox Dominance Amidst Rising Competition January 11, 2024 AbbVie Inc's (NYSE: ABBV) unwavering confidence in Botox's resilience within the aesthetics market with a commanding 68% market share remains steadfast. Despite a recent FDA petition addressing... Via Benzinga Exposures Product Safety Evolus Announces the Appointment of Nareg Sagherian to Vice President, Head of Global Investor Relations and Corporate Communications January 04, 2024 From Evolus Via Business Wire Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe December 20, 2023 From Evolus Via Business Wire Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings December 12, 2023 Consumer advocacy group Public Citizen has filed a petition with the FDA, urging the agency to demand stronger warnings regarding the risk of a potentially fatal muscle-paralyzing disease linked to... Via Benzinga Exposures Product Safety Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 08, 2023 From Evolus Via Business Wire Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 10, 2023 From Evolus Via Business Wire Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session November 08, 2023 Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday. Via Benzinga Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday November 08, 2023 U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Wednesday's Pre-Market Session November 08, 2023 Via Benzinga Why American Public Education Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket November 08, 2023 Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares surged 332% to $0.6455 in pre-market trading after falling over 7% on Tuesday. Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session November 07, 2023 Via Benzinga Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau® November 07, 2023 From Evolus Via Business Wire “Extra-Strength” 40U Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Phase II Data Presented at 2023 ASDS Annual Meeting November 06, 2023 From Evolus Via Business Wire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.